rs9928278

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001009944.3(PKD1):​c.8949-17A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 1,610,012 control chromosomes in the GnomAD database, including 29,785 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 6793 hom., cov: 33)
Exomes 𝑓: 0.16 ( 22992 hom. )

Consequence

PKD1
NM_001009944.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.41

Publications

10 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 16-2102650-T-C is Benign according to our data. Variant chr16-2102650-T-C is described in ClinVar as Benign. ClinVar VariationId is 257034.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.493 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.8949-17A>G intron_variant Intron 24 of 45 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.8949-17A>G intron_variant Intron 24 of 45 1 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.253
AC:
38407
AN:
152008
Hom.:
6771
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.499
Gnomad AMI
AF:
0.0978
Gnomad AMR
AF:
0.186
Gnomad ASJ
AF:
0.232
Gnomad EAS
AF:
0.00174
Gnomad SAS
AF:
0.0714
Gnomad FIN
AF:
0.190
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.163
Gnomad OTH
AF:
0.241
GnomAD2 exomes
AF:
0.160
AC:
39456
AN:
246746
AF XY:
0.154
show subpopulations
Gnomad AFR exome
AF:
0.517
Gnomad AMR exome
AF:
0.112
Gnomad ASJ exome
AF:
0.231
Gnomad EAS exome
AF:
0.000274
Gnomad FIN exome
AF:
0.184
Gnomad NFE exome
AF:
0.164
Gnomad OTH exome
AF:
0.174
GnomAD4 exome
AF:
0.164
AC:
239165
AN:
1457886
Hom.:
22992
Cov.:
35
AF XY:
0.161
AC XY:
116601
AN XY:
725288
show subpopulations
African (AFR)
AF:
0.513
AC:
17129
AN:
33368
American (AMR)
AF:
0.121
AC:
5419
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
6157
AN:
26116
East Asian (EAS)
AF:
0.000403
AC:
16
AN:
39698
South Asian (SAS)
AF:
0.0752
AC:
6480
AN:
86168
European-Finnish (FIN)
AF:
0.182
AC:
9448
AN:
52024
Middle Eastern (MID)
AF:
0.231
AC:
1002
AN:
4344
European-Non Finnish (NFE)
AF:
0.165
AC:
182880
AN:
1111296
Other (OTH)
AF:
0.177
AC:
10634
AN:
60168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
11910
23819
35729
47638
59548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6586
13172
19758
26344
32930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.253
AC:
38474
AN:
152126
Hom.:
6793
Cov.:
33
AF XY:
0.247
AC XY:
18391
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.499
AC:
20705
AN:
41484
American (AMR)
AF:
0.186
AC:
2840
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.232
AC:
804
AN:
3468
East Asian (EAS)
AF:
0.00174
AC:
9
AN:
5172
South Asian (SAS)
AF:
0.0708
AC:
342
AN:
4828
European-Finnish (FIN)
AF:
0.190
AC:
2017
AN:
10590
Middle Eastern (MID)
AF:
0.252
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
0.163
AC:
11089
AN:
67970
Other (OTH)
AF:
0.239
AC:
505
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1374
2748
4123
5497
6871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
352
704
1056
1408
1760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.206
Hom.:
1868
Bravo
AF:
0.264
Asia WGS
AF:
0.0730
AC:
255
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 25, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease, adult type Benign:1
Jul 07, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant polycystic kidney disease Benign:1
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.7
DANN
Benign
0.37
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9928278; hg19: chr16-2152651; COSMIC: COSV51924588; COSMIC: COSV51924588; API